Torrent Pharmaceuticals Limited - Balance (Quarterly)

Torrent Pharmaceuticals Limited
IN ˙ BSE
4.191,50 ₹ ↓ -38,60 (-0,91%)
2026-04-30
DEL PRIS
Balance (Quarterly)

Torrent Pharmaceuticals Limited Balance viser kontosaldi for virksomheden på tidspunkter. Balancedata inkluderer aktiver, omsætningsaktiver, anlægsaktiver, materielle anlægsaktiver (PPE), inventar, immaterielle aktiver, passiver, kortfristede forpligtelser, gæld, kapitalleasingforpligtelser, almindelige aktier, overført overskud, egne aktier og egenkapital.

Alle tal er gange 1,000,000.00 undtagen pr. andel enheder.

2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
2025
09-30
Kontanter 3.450 3.984 3.480 5.085 5.560 8.390 11.500 5.735 7.050
Ændring (%) 15,48 -12,65 46,13 9,33 50,90 37,07 -50,13 22,93
Aktiver Nuværende 53.590 52.946 53.490 53.292 52.870 56.115 58.790 56.226 61.920
Ændring (%) -1,20 1,03 -0,37 -0,79 6,14 4,77 -4,36 10,13
Aktiver 136.830 130.998 132.190 150.118 147.440 150.610 150.880 149.897 155.150
Ændring (%) -4,26 0,91 13,56 -1,78 2,15 0,18 -0,65 3,50
Forpligtelser 74.640 71.469 71.280 88.138 80.370 82.050 75.840 73.990 70.660
Ændring (%) -4,25 -0,26 23,65 -8,81 2,09 -7,57 -2,44 -4,50
Egenkapital 62.190 59.530 60.910 61.981 67.070 68.562 75.040 75.907 84.490
Ændring (%) -4,28 2,32 1,76 8,21 2,22 9,45 1,16 11,31
Passiver og Aktiekapital 136.830 130.998 132.190 150.118 147.440 150.610 150.880 149.897 155.150
Ændring (%) -4,26 0,91 13,56 -1,78 2,15 0,18 -0,65 3,50

Source: Capital IQ

Other Listings
IN:TORNTPHARM 4.115,80 ₹
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista